CJC-1295 + Ipamorelin 5+5mg Pre-blended vial containing CJC-1295 (no DAC), a modified GRF(1-29) analogue, and Ipamorelin, a selective ghrelin receptor pentapeptide agonist
Learning Objectives Upon completion of the Advanced Weight Management Certification program, the physician should be able to: Learn about the latest weight loss programs and protocols available including: GLP-1 Agonist Training: Receive in-depth instruction on the use of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy), in weight loss treatments
IP3 may help liberate calcium ions (Ca) from internal cellular stores
When Microdosing May Not Be Appropriate Microdosing is not appropriate when core safety or metabolic foundations have not been addressed
Magnesium in Prevention and Therapy
People with recurrent UTI history If you have a history of three or more UTIs in the past year, or two or more in the past six months, you are classified as having recurrent UTIs